BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8538025)

  • 1. [Malignant glioma].
    Okamura K
    Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes and glial tumors.
    Watkins D; Rouleau GA
    Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; PestaƱa A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology in cerebral gliomas: recent advances].
    Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
    Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of brain tumors.
    Wu JK; Naber SP
    Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of molecular development of human glioma].
    Schlegel U
    Nervenarzt; 1993 Aug; 64(8):485-93. PubMed ID: 8413746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
    Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
    Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.
    Chernova OB; Somerville RP; Cowell JK
    Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific chromosomal abnormalities in malignant human gliomas.
    Bigner SH; Mark J; Burger PC; Mahaley MS; Bullard DE; Muhlbaier LH; Bigner DD
    Cancer Res; 1988 Jan; 48(2):405-11. PubMed ID: 3335011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.